Shopping Cart
- Remove All
Your shopping cart is currently empty
Tapotoclax (AMG-176) is an orally active MCL1 inhibitor for the study of myeloid leukemia.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $479 | In Stock | |
| 5 mg | $1,590 | In Stock | |
| 10 mg | $2,180 | In Stock | |
| 25 mg | $3,230 | In Stock | |
| 50 mg | $4,370 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $1,970 | In Stock |
| Description | Tapotoclax (AMG-176) is an orally active MCL1 inhibitor for the study of myeloid leukemia. |
| Targets&IC50 | MCL1:0.13 nM (Ki) |
| In vitro | Tapotoclax is a potent inhibitor (Ki=0.13 nM) of the inducible myeloid leukemia cell differentiation protein MCL-1, with potential pro-apoptotic and anti-tumor activity. Upon administration, Tapotoclax binds to MCL-1, thereby inhibiting its function. This process prevents the formation of a complex between MCL-1 and Bcl-2-like protein 11 (BCL2L11; BIM) and further triggers apoptosis in tumor cells. [2] |
| Synonyms | AMG-176, AMG176 |
| Molecular Weight | 613.21 |
| Formula | C33H41ClN2O5S |
| Cas No. | 1883727-34-1 |
| Smiles | C[C@H]1C/C=C/[C@@H]([C@@H]2CC[C@H]2CN3C[C@@]4(CCCC5=C4C=CC(=C5)Cl)COC6=C3C=C(C=C6)C(=O)NS(=O)(=O)[C@@H]1C)OC |
| Relative Density. | 1.32 g/cm3 (Predicted) |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (81.54 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.